Suppr超能文献

与你的微生物群共生:细菌微生物群如何影响眼表健康与疾病

Living with your biome: how the bacterial microbiome impacts ocular surface health and disease.

作者信息

Lai James, Rigas Yannis, Kantor Nicole, Cohen Noah, Tomlinson Ana, St Leger Anthony J, Galor Anat

机构信息

Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.

University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Expert Rev Ophthalmol. 2024;19(2):89-103. doi: 10.1080/17469899.2024.2306582. Epub 2024 Feb 4.

Abstract

INTRODUCTION

Microbiome research has grown exponentially but the ocular surface microbiome (OSM) remains an area in need of further study. This review aims to explore its complexity, disease-related microbial changes, and immune interactions, and highlights the potential for its manipulation as a therapeutic for ocular surface diseases.

AREAS COVERED

We introduce the OSM by location and describe what constitutes a normal OSM. Second, we highlight aspects of the ocular immune system and discuss potential immune microbiome interactions in health and disease. Finally, we highlight how microbiome manipulation may have therapeutic potential for ocular surface diseases.

EXPERT OPINION

The ocular surface microbiome varies across its different regions, with a core phyla identified, but with genus variability. A few studies have linked microbiome composition to diseases like dry eye but more research is needed, including examining microbiome interactions with the host. Studies have noted that manipulating the microbiome may impact disease presentation. As such, microbiome manipulation via diet, oral and topical pre and probiotics, and hygienic measures may provide new therapeutic algorithms in ocular surface diseases.

摘要

引言

微生物组研究呈指数级增长,但眼表微生物组(OSM)仍是一个需要进一步研究的领域。本综述旨在探讨其复杂性、与疾病相关的微生物变化以及免疫相互作用,并强调其作为眼表疾病治疗手段进行调控的潜力。

涵盖领域

我们按位置介绍眼表微生物组,并描述构成正常眼表微生物组的要素。其次,我们强调眼免疫系统的各个方面,并讨论健康和疾病状态下潜在的免疫微生物组相互作用。最后,我们强调微生物组调控如何可能对眼表疾病具有治疗潜力。

专家观点

眼表微生物组在其不同区域存在差异,已确定了核心门类,但属水平存在变异性。一些研究已将微生物组组成与干眼症等疾病联系起来,但仍需要更多研究,包括研究微生物组与宿主的相互作用。研究指出,调控微生物组可能会影响疾病表现。因此,通过饮食、口服和局部使用益生元和益生菌以及卫生措施来调控微生物组,可能会为眼表疾病提供新的治疗方案。

相似文献

2
Microbiome and immune-mediated dry eye: a review.微生物组与免疫介导性干眼症:综述。
BMJ Open Ophthalmol. 2022 Jun;7(1). doi: 10.1136/bmjophth-2021-000956.
3
The ocular surface microbiome of rhesus macaques.恒河猴的眼表微生物群
Res Sq. 2025 Mar 14:rs.3.rs-6205866. doi: 10.21203/rs.3.rs-6205866/v1.
8
Microbiome-based therapeutics for ocular diseases.基于微生物组的眼部疾病治疗方法。
Clin Exp Optom. 2025 Mar;108(2):115-122. doi: 10.1080/08164622.2024.2422479. Epub 2024 Dec 1.
9
Assessing the ocular surface microbiome in severe ocular surface diseases.评估严重眼表疾病的眼表微生物组。
Ocul Surf. 2020 Oct;18(4):706-712. doi: 10.1016/j.jtos.2020.07.007. Epub 2020 Jul 24.

本文引用的文献

5
Ocular surface microbiome in diabetes mellitus.糖尿病患者的眼表面微生物组。
Sci Rep. 2022 Dec 13;12(1):21527. doi: 10.1038/s41598-022-25722-0.
6
Ocular surface microbiota: Ophthalmic infectious disease and probiotics.眼表微生物群:眼科传染病与益生菌
Front Microbiol. 2022 Aug 19;13:952473. doi: 10.3389/fmicb.2022.952473. eCollection 2022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验